Skip to main content
Clinical Trials/NCT05417451
NCT05417451
Completed
Phase 2

Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors

University of Illinois at Chicago1 site in 1 country46 target enrollmentNovember 1, 2021
ConditionsBreast Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
University of Illinois at Chicago
Enrollment
46
Locations
1
Primary Endpoint
PROMIS Pain Interference
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

The objectives of this study to explore whether acupuncture can improve the psychoneurological symptom cluster (pain, fatigue, sleep disturbance) in survivors of breast cancer and explore biomarker changes after the acupuncture intervention. Acupuncture treatments will be provided to breast cancer survivors twice weekly for 5 weeks.

Detailed Description

The investigators will conduct the study with early stage breast cancer survivors who have completed their primary cancer treatment. They will all receive acupuncture. Treatments will be twice weekly for 5 weeks, for 30 minutes per treatment. At baseline and post-treatment, subjects will be collected blood and stool samples, complete symptom questionnaires that measure pain, fatigue, and sleep disturbance.

Registry
clinicaltrials.gov
Start Date
November 1, 2021
End Date
February 26, 2025
Last Updated
9 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hongjin Li

Assistant Professor

University of Illinois at Chicago

Eligibility Criteria

Inclusion Criteria

  • women with histologically confirmed stage 0, I, II, or III breast cancer
  • who have completed their primary cancer treatment (e.g., surgery, radiotherapy, chemotherapy) at least 3 months prior and within 5 years
  • are currently receiving adjuvant endocrine therapy
  • are able to read and speak English
  • with self-reported pain, fatigue, sleep disturbance in the last three months and their "worst" severity rating ≥ 3 (0-10 numeric rating scale) for at least two of the three symptoms

Exclusion Criteria

  • have self-reported hospitalization for psychiatric illness within the past 2 years
  • have a bleeding disorder
  • physically or cognitively unable to complete the study procedures
  • pregnant women

Outcomes

Primary Outcomes

PROMIS Pain Interference

Time Frame: After 10th acupuncture treatment, at 6 weeks post-baseline (study completion)

Scores range from 4-20; higher scores indicate that pain is interfering with daily activities more

PROMIS Fatigue

Time Frame: After 10th acupuncture treatment, at 6 weeks post-baseline (study completion)

Scores range from 4-20; higher scores indicate that severe fatigue

PROMIS Sleep Disturbance

Time Frame: After 10th acupuncture treatment, at 6 weeks post-baseline (study completion)

Scores range from 4-20; higher scores indicate that severe sleep disturbance

Secondary Outcomes

  • PROMIS Depression(After 10th acupuncture treatment, at 6 weeks post-baseline (study completion))
  • PROMIS Anxiety(After 10th acupuncture treatment, at 6 weeks post-baseline (study completion))

Study Sites (1)

Loading locations...

Similar Trials